Abstract:A critically evaluated database of human intestinal absorption for 648 chemical compounds is reported in this study, among which 579 are believed to be transported by passive diffusion. The correlation analysis between the intestinal absorption and several important molecular properties demonstrated that no single molecular property could be used as a good discriminator to efficiently distinguish the poorly absorbed compounds from those that are well absorbed. The theoretical correlation models for a training set of 455 compounds were proposed by using the genetic function approximation technique. The best prediction model contains four molecular descriptors: topological polar surface area, the predicted distribution coefficient at pH = 6.5, the number of violations of the Lipinski's rule-of-five, and the square of the number of hydrogen-bond donors. The model was able to predict the fractional absorption with an r = 0.84 and a prediction error (absolute mean error) of 11.2% for the training set. Moreover, it achieves an r = 0.90 and a prediction error of 7.8% for a 98-compound test set. The recursive partitioning technique was applied to find the simple hierarchical rules to classify the compounds into poor (%FA < or = 30%) and good (%FA > 30%) intestinal absorption classes. The high quality of the classification model was validated by the satisfactory predictions on the training set (correctly identifying 95.9% of the compounds in the poor-absorption class and 96.1% of the compounds in the good-absorption class) and on the test set (correctly identifying 100% of the compounds in the poor-absorption class and 96.8% of the compounds in the good-absorption class). We expect that, in the future, the rules for the prediction of carrier-mediated transporting and first pass metabolism can be integrated into the current hierarchical rules, and the classification model may become more powerful in the prediction of intestinal absorption or even human bioavailability. The databases of human intestinal absorption reported here are available for download from the supporting Web site: http://modem.ucsd.edu/adme.

ADME Evaluation in Drug Discovery. Part 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property‐Based Rules?

ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules?

ADME Evaluation in Drug Discovery. Part 7. Prediction of Oral Absorption by Correlation and Classification.

ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.

ChemInform Abstract: ADME Evaluation in Drug Discovery. Part 8. the Prediction of Human Intestinal Absorption by a Support Vector Machine.

ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.

ADME Evaluation in Drug Discovery. Part 4. Prediction of Aqueous Solubility Based on Atom Contribution Approach.

Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap.

ADME Evaluation in Drug Discovery. 2. Prediction of Partition Coefficient by Atom-Additive Approach Based on Atom-Weighted Solvent Accessible Surface Areas [J. Chem. Inf. Comput. Sci. 43, 1058−1067 (2003)]

ADME Evaluation in Drug Discovery. Part 2. Prediction of Partition Coefficient by Atom‐Additive Approach Based on Atom‐Weighted Solvent Accessible Surface Areas.

Structure-ADME relationship: still a long way to go?

ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors [J. Chem. Inf. Comput. Sci. 43, 2137-2152 (2003)]

Recent Advances On In Silico Adme Modeling

Structure – ADME Relationship: Still a Long Way to Go?

Adme-Ap: A Database of Adme Associated Proteins

Predicting ADME properties in silico: methods and models

Advances in Computationally Modeling Human Oral Bioavailability.

Recent developments of in silico predictions of oral bioavailability.

ADME Evaluation in Drug Discovery. Part 5. Correlation of Caco‐2 Permeation with Simple Molecular Properties.

Computational modeling of human oral bioavailability: what will be next?

Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery